Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SOXL vs GSK✓SelectedUSD · GSKSOXL vs GSK performance historyLatest closeAs of-16.39%11/16
Stock and ETF performance explorer

SOXL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+114.6%
GSK return
+62.7%
Excess return
+51.9%
Maximum drawdown
-87.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-16.4%-0.1%-16.3%-16.4%
7D-13.2%-1.3%-11.9%-13.3%
30D-47.9%+2.7%-50.7%-47.8%
3M-66.3%+2.7%-69.1%-66.2%
6M-70.3%+3.3%-73.6%-70.7%
YTD+16.1%+6.5%+9.6%+13.5%
1Y+25.6%+10.7%+14.9%+21.2%
All+114.6%+62.7%+51.9%+94.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling